Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-13571.9China
BA.5.1.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.4.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.4.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BK.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-17009France
BK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BK.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DJ.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
DJ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DJ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DJ.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.11.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.11.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.11.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EE.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
BN.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BY.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used